PIH18 Cost-Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccination In Kazakhstan

Система будет остановлена для регулярного обслуживания. Пожалуйста, сохраните рабочие данные и выйдите из системы.

dc.contributor.author	Bektur, C
dc.contributor.author	Nurgozhin, T
dc.creator	C, Bektur
dc.date.accessioned	2017-12-13T09:45:05Z
dc.date.available	2017-12-13T09:45:05Z
dc.date.issued	2015-05-01
dc.identifier	DOI:10.1016/j.jval.2015.03.624
dc.identifier.citation	C Bektur, T Nurgozhin, PIH18 - Cost-Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccination In Kazakhstan, In Value in Health, Volume 18, Issue 3, 2015, Page A106
dc.identifier.issn	10983015
dc.identifier.uri	https://www.sciencedirect.com/science/article/pii/S1098301515006816
dc.identifier.uri	http://nur.nu.edu.kz/handle/123456789/2877
dc.description.abstract	The aim of the study was to investigate the cost-effectiveness of 13-valent pneumococcal conjugate vaccine (PCV-13) programme for children in Kazakhstan from the perspective of Ministry of Health.
dc.publisher	Value in Health
dc.relation.ispartof	Value in Health
dc.title	PIH18 Cost-Effectiveness Of 13-Valent Pneumococcal Conjugate Vaccination In Kazakhstan
dc.type	Article
dc.rights.license	Copyright © 2015 Published by Elsevier Inc.
elsevier.identifier.doi	10.1016/j.jval.2015.03.624
elsevier.identifier.eid	1-s2.0-S1098301515006816
elsevier.identifier.pii	S1098-3015(15)00681-6
elsevier.volume	18
elsevier.issue.identifier	3
elsevier.coverdate	2015-05-01
elsevier.coverdisplaydate	May 2015
elsevier.startingpage	A106
elsevier.openaccess	1
elsevier.openaccessarticle	true
elsevier.openarchivearticle	true
elsevier.openaccessuserlicense	http://www.elsevier.com/open-access/userlicense/1.0/
elsevier.aggregationtype	Journal